期刊文献+

单纯疱疹病毒2型ICP27_(377-513)核酸疫苗联合IL-15核酸疫苗免疫效果的观察

Observation of the immunization effect of HSV-2 ICP27_(377-513) DNA vaccine combined with IL-15 DNA vaccine
下载PDF
导出
摘要 目的构建表达单纯疱疹病毒2型感染细胞蛋白27(infected cells protein 27,ICP27)的重组质粒pcDNA3.1-ICP27377-513并观察白细胞介素(IL)-15核酸疫苗联合HSV-2-ICP27377-513核酸疫苗的免疫效果。方法采用分子克隆技术构建pcDNA3.1-ICP27377-513重组质粒。将BALB/c雌性小鼠随机分为pcDNA3.1-ICP27377-513联合pcDNA3.1-IL-15(pIL-15)组、pcDNA3.1-ICP27377-513组、pcDNA3.1组和pIL-15组,共免疫3次,每次间隔2周。末次免疫后28 d取血,用微量中和实验法检测血清中特异性中和抗体,ELISA法检测血清中IL-4、IL-2和干扰素-γ(IFN-γ)水平。阴道给予致死量HSV-2攻击小鼠,分别于接种后3 d、7 d和14 d收集阴道冲洗液,用荧光定量PCR法检测生殖道病毒载量。结果pcDNA3.1-ICP27377-513联合pIL-15组和pcDNA3.1-ICP27377-513组中和抗体效价分别为40.00±8.16、28.67±4.47,但两组间差异无统计学意义(P>0.05)。pcDNA3.1-ICP27377-513联合pIL-15组IFN-γ、IL-4水平明显高于pcDNA3.1-ICP27377-513组(P<0.05),但IL-2水平两组间差异无统计学意义(P>0.05)。阴道给予致死量HSV-2攻击后,pcDNA3.1-ICP27377-513联合pIL-15组和pcDNA3.1-ICP27377-513组小鼠阴道冲洗液中病毒载量随着时间延长逐渐减低,pcDNA3.1-ICP27377-513联合pIL-15组和pcDNA3.1-ICP27377-513组相比差异有统计学意义(P<0.05)。结论IL-15核酸疫苗联合HSV-2-ICP27377-513核酸疫苗对小鼠有较好的免疫保护作用。 Objective To construct a recombinant plasmid pcDNA3.1-ICP27377-513 expressing infected cells protein 27(ICP27)of herpes simplex virus type 2(HSV-2)and observe the immune effect of IL-15 DNA vaccine combined with HSV-2-ICP27377-513 DNA vaccine.Methods Molecular cloning technology was used to construct the pcDNA3.1-ICP27377-513 recombinant plasmid.Female BALB/c mice were randomly divided into four groups:pcDNA3.1-ICP27377-513 combined with pcDNA3.1-IL-15(pIL-15)group,pcDNA3.1-ICP27377-513 group,pcDNA3.1 group,and pIL-15 group.Mice were immunized three times at two-week intervals.Blood was collected 28 days after the final immunization to detect specific neutralizing antibodies in the serum using a micro-neutralization assay,and the levels of IL-4,IL-2,and IFN-γin serum were measured using ELISA.Mice were challenged with a lethal dose of HSV-2 in the vagina,and vaginal lavage fluid was collected at 3,7,and 14 days post-inoculation to detect viral load using quantitative fluorescence PCR.Results The neutralizing antibody titers in the pcDNA3.1-ICP27377-513 combined with pIL-15 group(first combined group)and pcDNA3.1-ICP27377-513 group were 40.00±8.16 and 28.67±4.47,respectively,with no statistically significant difference between the two groups(P>0.05).The levels of IFN-γand IL-4 in the first combined group were significantly higher than those in the pcDNA3.1-ICP27377-513 group(P<0.05),but there was no significant difference in IL-2 levels between the two groups(P>0.05).After vaginal inoculation with a lethal dose of HSV-2,the viral load in vaginal lavage fluid gradually decreased over time in both the first combined group and the pcDNA3.1-ICP27377-513 group,with a statistically significant difference between the two groups(P<0.05).Conclusion IL-15 DNA vaccine combined with HSV-2-ICP27377-513 DNA vaccine has a good immune protective effect on mice.
作者 韩小艳 吴振村 周艳 贾凤珍 王晨红 HAN Xiao-yan;WU Zhen-cun;ZHOU Yan;JIA Feng-zhen;WANG Chen-hong(College of Laboratory Medicine,Hebei North University,Zhangjiakou 075000,Hebei,China;不详)
出处 《广东医学》 CAS 2024年第5期566-570,共5页 Guangdong Medical Journal
基金 河北省科技计划项目(152777110) 张家口市科学技术研究与发展计划项目(17120013D)。
关键词 单纯疱疹病毒2型 感染细胞蛋白27 白细胞介素15 核酸疫苗 herpes simplex virus 2 infected cells protein 27 IL-15 DNA vaccine
  • 相关文献

参考文献5

二级参考文献42

  • 1Yuan-Xiang Zhou,Maggie Yuk-Ting Lee,James Ming-Him Ng,Mee-Len Chye,Wing-Kin Yip,Sze-Yong Zee,Eric Lam.A truncated hepatitis E virus ORF2 protein expressed in tobacco plastids is immunogenic in mice[J].World Journal of Gastroenterology,2006,12(2):306-312. 被引量:10
  • 2Koelle D M. Vaccines for herpes simplex virus infections[J]. Curr Opin Investing Drugs,2006,7(2) : 136-141.
  • 3Manservigi R, Boero A, Argnani R. Immunotherapeutic activity of a recombinant combined gB-gD-gE vaccine against recurrent HSV-2 infections in a guinea pig model[J]. Vaccine, 2005,23(7) : 865-872.
  • 4Rupp R, Rosenthal S L, Stanberry L R. Pediatrics and herpes simplex virus vaeeines[J]. Semin Pediatr Infect Dis, 2005.16 (1) : 31-37.
  • 5Bourne N, Bravo F J, Francotte M, et al. Herpes simplex virus (HSV) type 2 glycoprotein D subunit vaccines and protection against genital HSV-1 or HSV-2 disease in guinea pigs[J]. J Infect Dis,2003,187(4) :542-549.
  • 6Morrison L A, Da Costa X J, Knipe D M. Influence of mucosal and parenteral immunization with a replication-defective mutant of HSV-2 on immune responses and protection from genital challenge[J]. Virology, 1998,243(1) : 178-187.
  • 7Juan Flo. Co-immunization with plasmids coding the full length and a soluble form of glycoprotein D of HSV-2 induces protective cellular and humoral immune response in mice[J]. Vaccine,2003, 21 (11-12):1239-1245.
  • 8焦茂兴,吴锋,刘德辉,黄毓茂.猪流行性腹泻病毒重组腺病毒疫苗的构建及小鼠免疫试验[J].中国畜牧兽医,2012,39(2):11-16. 被引量:25
  • 9金宏丽,王化磊,郑学星,杨松涛,夏咸柱.埃博拉病毒病疫苗研究进展[J].传染病信息,2015,28(2):70-74. 被引量:8
  • 10Naru Zhang,Rudragouda Channappanavar,Cuiqing Ma,Lili Wang,Jian Tang,Tania Garron,Xinrong Tao,Sumaiya Tasneem,Lu Lu,Chien-Te K Tseng,Yusen Zhou,Stanley Perlman,Shibo Jiang,Lanying Du.Identification of an ideal adjuvant for receptor-binding domain-based subunit vaccines against Middle East respiratory syndrome coronavirus[J].Cellular & Molecular Immunology,2016,13(2):180-190. 被引量:13

共引文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部